Gelteq最新发布的临床前研究数据显示，其独创的口服凝胶递送技术能有效促进药用大麻素的生物利用度。实验结果表明，该平台通过独特的凝胶基质结构，在模拟人体消化环境条件下使活性成分的渗透效率提升显著。这一突破性技术有望解决传统口服制剂吸收不稳定的行业痛点，为药用大麻素疗法的精准给药开辟新路径。
Gelteq最新发布的临床前研究数据显示，其独创的口服凝胶递送技术能有效促进药用大麻素的生物利用度。实验结果表明，该平台通过独特的凝胶基质结构，在模拟人体消化环境条件下使活性成分的渗透效率提升显著。这一突破性技术有望解决传统口服制剂吸收不稳定的行业痛点，为药用大麻素疗法的精准给药开辟新路径。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.